???pagination.result.count???
Xrel3 is required for head development in Xenopus laevis. , Lake BB, Ford R, Kao KR ., Development. January 1, 2001; 128 (2): 263-73.
Critical residues of epitopes recognized by several anti- p53 monoclonal antibodies correspond to key residues of p53 involved in interactions with the mdm2 protein. , Portefaix JM, Thebault S, Bourgain-Guglielmetti F, Del Rio M, Granier C, Mani JC, Navarro-Teulon I, Nicolas M, Soussi T, Pau B., J Immunol Methods. October 20, 2000; 244 (1-2): 17-28.
The Mdm2 gene of zebrafish (Danio rerio): preferential expression during development of neural and muscular tissues, and absence of tumor formation after overexpression of its cDNA during early embryogenesis. , Thisse C, Neel H, Thisse B, Daujat S, Piette J., Differentiation. October 1, 2000; 66 (2-3): 61-70.
Cell-cycle regulation of the p53-inducible gene B99. , Collavin L, Monte M, Verardo R, Pfleger C, Schneider C., FEBS Lett. September 8, 2000; 481 (1): 57-62.
Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage. , Costanzo V, Robertson K, Ying CY, Kim E , Avvedimento E, Gottesman M, Grieco D, Gautier J ., Mol Cell. September 1, 2000; 6 (3): 649-59.
Form of human p53 protein during nuclear transport in Xenopus laevis embryos. , Hara T, Arai K, Koike K., Exp Cell Res. July 10, 2000; 258 (1): 152-61.
A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. , Kim RH, Wang D, Tsang M , Martin J, Huff C, de Caestecker MP, Parks WT, Meng X, Lechleider RJ, Wang T, Roberts AB ., Genes Dev. July 1, 2000; 14 (13): 1605-16.
The amyloid beta peptide abeta (25-35) induces apoptosis independent of p53. , Blasko I, Wagner M, Whitaker N, Grubeck-Loebenstein B, Jansen-Dürr P., FEBS Lett. March 24, 2000; 470 (2): 221-5.
T-antigen interactions with chromatin and p53 during the cell cycle in extracts from xenopus eggs. , Vassetzky YS, Tchang F, Fanning E, Méchali M., J Cell Biochem. November 1, 1999; 75 (2): 288-99.
Nuclear import of p53 during Xenopus laevis early development in relation to DNA replication and DNA repair. , Tchang F, Méchali M., Exp Cell Res. August 25, 1999; 251 (1): 46-56.
Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53. , Chène P., J Mol Biol. May 21, 1999; 288 (5): 883-90.
A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. , Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM., EMBO J. March 15, 1999; 18 (6): 1660-72.
Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy? , Cochet O, Gruel N, Fridman WH, Teillaud JL., Cancer Detect Prev. January 1, 1999; 23 (6): 506-10.
Production of a polyclonal antibody raised against recombinant flounder p53 protein. , Cachot J, Galgani F, Vincent F., Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. October 1, 1998; 120 (3): 351-6.
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F., Mol Cell. September 1, 1998; 2 (3): 305-16.
Overexpression of a novel Xenopus rel mRNA gene induces tumors in early embryos. , Yang S, Lockwood A, Hollett P, Ford R, Kao K ., J Biol Chem. May 29, 1998; 273 (22): 13746-52.
Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein. , Bessard AC, Garay E, Lacronique V, Legros Y, Demarquay C, Houque A, Portefaix JM, Granier C, Soussi T., Oncogene. February 19, 1998; 16 (7): 883-90.
[A large T-antigen of SV40 virus: involvement in replication of cellular DNA and interactions with nuclear proteins]. , Vasetskiĭ ES, Meshali M., Ontogenez. January 1, 1998; 29 (3): 170-7.
A functional analysis of p53 during early development of Xenopus laevis. , Amariglio F, Tchang F, Prioleau MN, Soussi T, Cibert C, Méchali M., Oncogene. October 1, 1997; 15 (18): 2191-9.
p53 activity is essential for normal development in Xenopus. , Wallingford JB , Seufert DW , Virta VC, Vize PD ., Curr Biol. October 1, 1997; 7 (10): 747-57.
p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. , Saha P, Eichbaum Q, Silberman ED, Mayer BJ, Dutta A ., Mol Cell Biol. August 1, 1997; 17 (8): 4338-45.
Cloning of the p53 tumor suppressor gene from the Japanese medaka (Oryzias latipes) and evaluation of mutational hotspots in MNNG-exposed fish. , Krause MK, Rhodes LD, Van Beneden RJ., Gene. April 11, 1997; 189 (1): 101-6.
Conservation of structural domains and biochemical activities of the MDM2 protein from Xenopus laevis. , Marechal V, Elenbaas B, Taneyhill L, Piette J, Mechali M , Nicolas JC, Levine AJ, Moreau J ., Oncogene. March 27, 1997; 14 (12): 1427-33.
B- Myb, a repressed trans-activating protein. , Ansieau S, Kowenz-Leutz E, Dechend R, Leutz A., J Mol Med (Berl). January 1, 1997; 75 (11-12): 815-9.
Biochemical properties of Xenopus laevis p53. , Hoever M, Herrmann C, Montenarh M., Int J Oncol. January 1, 1997; 10 (1): 195-203.
Tumour suppressor gene p53 in the horse: identification, cloning, sequencing and a possible role in the pathogenesis of equine sarcoid. , Bucher K, Szalai G, Marti E, Griot-Wenk ME, Lazary S, Pauli U., Res Vet Sci. September 1, 1996; 61 (2): 114-9.
Cyclin-binding motifs are essential for the function of p21CIP1. , Chen J , Saha P, Kornbluth S , Dynlacht BD, Dutta A ., Mol Cell Biol. September 1, 1996; 16 (9): 4673-82.
The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype. , Levine AJ, Wu MC, Chang A, Silver A, Attiyeh EF, Lin J, Epstein CB., Ann N Y Acad Sci. September 30, 1995; 768 111-28.
A direct effect of activated human p53 on nuclear DNA replication. , Cox LS, Hupp T, Midgley CA, Lane DP., EMBO J. May 1, 1995; 14 (9): 2099-105.
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. , Chen J , Jackson PK , Kirschner MW , Dutta A ., Nature. March 23, 1995; 374 (6520): 386-8.
Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerization are evolutionarily conserved. , Wang Y, Farmer G, Soussi T, Prives C., Oncogene. February 16, 1995; 10 (4): 779-84.
Fission yeast tmsl protein abrogates normal development in Xenopus laevis embryos. , Wagner P, Hoever M, Appel K, Knöchel W , Montenarh M., Rouxs Arch Dev Biol. January 1, 1995; 204 (3): 198-202.
Expression of a homologue of the deleted in colorectal cancer ( DCC) gene in the nervous system of developing Xenopus embryos. , Pierceall WE, Reale MA, Candia AF , Wright CV , Cho KR , Fearon ER., Dev Biol. December 1, 1994; 166 (2): 654-65.
Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. , Shivji MK, Grey SJ, Strausfeld UP, Wood RD, Blow JJ ., Curr Biol. December 1, 1994; 4 (12): 1062-8.
Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression. , Ridgway PJ, Soussi T, Braithwaite AW., J Virol. November 1, 1994; 68 (11): 7178-87.
Xenopus p53 is biochemically similar to the human tumour suppressor protein p53 and is induced upon DNA damage in somatic cells. , Cox LS, Midgley CA, Lane DP., Oncogene. October 1, 1994; 9 (10): 2951-9.
Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. , Strausfeld UP, Howell M, Rempel R, Maller JL , Hunt T , Blow JJ ., Curr Biol. October 1, 1994; 4 (10): 876-83.
A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis. , Nigro V, Napolitano M, Abbondanza C, Medici N, Puca AA, Schiavulli M, Armetta I, Moncharmont B, Puca GA, Molinari AM., Cancer Lett. April 29, 1994; 79 (1): 73-5.
The canine p53 gene is subject to somatic mutations in thypoid carcinoma. , Devilee P, Van Leeuwen IS, Voesten A, Rutteman GR, Vos JH, Cornelisse CJ., Anticancer Res. January 1, 1994; 14 (5A): 2039-46.
Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos. , Hoever M, Clement JH, Wedlich D , Montenarh M, Knöchel W ., Oncogene. January 1, 1994; 9 (1): 109-20.
Stabilization and expression of high levels of p53 during early development in Xenopus laevis. , Tchang F, Gusse M, Soussi T, Méchali M., Dev Biol. September 1, 1993; 159 (1): 163-72.
The Ets family of transcription factors. , Wasylyk B, Hahn SL, Giovane A., Eur J Biochem. January 15, 1993; 211 (1-2): 7-18.
Identification of RNA-binding proteins specific to Xenopus Eg maternal mRNAs: association with the portion of Eg2 mRNA that promotes deadenylation in embryos. , Legagneux V, Bouvet P, Omilli F, Chevalier S, Osborne HB ., Development. December 1, 1992; 116 (4): 1193-202.
Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library. , Stephen CW, Lane DP., J Mol Biol. June 5, 1992; 225 (3): 577-83.
p53 mutations in human cancers. , Hollstein M, Sidransky D, Vogelstein B, Harris CC., Science. July 5, 1991; 253 (5015): 49-53.
Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. , Bartek J, Iggo R, Gannon J, Lane DP., Oncogene. June 1, 1990; 5 (6): 893-9.
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. , Gannon JV, Greaves R, Iggo R, Lane DP., EMBO J. May 1, 1990; 9 (5): 1595-602.
Genes and mechanisms involved in early embryonic development in Xenopus laevis. , Méchali M, Almouzni G , Andéol Y, Moreau J , Vriz S, Leibovici M, Hourdry J, Géraudie J, Soussi T, Gusse M., Int J Dev Biol. March 1, 1990; 34 (1): 51-9.
Tumor suppressor genes. , Levine AJ., Bioessays. February 1, 1990; 12 (2): 60-6.
Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70. , Soussi T, Caron de Fromentel C, Stürzbecher HW, Ullrich S, Jenkins J, May P., J Virol. September 1, 1989; 63 (9): 3894-901.